Bayer Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients Bayer will offer Veracyte's Afirma Xpression Atlas to identify underlying drivers in tumors of late-stage or metastatic thyroid cancer patients resistant to radioactive iodine therapy. Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer The partners are starting by testing patients with colorectal and thyroid cancers using the 648-gene Tempus xT assay, but could expand to other areas in the future. FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients The test analyzes substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, along with some genomic signatures in solid tumors. ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development The firms are developing a kit-based CDx to detect NTRK gene fusions, including NTRK1, NTRK2 and NTRK3, for Bayer's Vitrakvi cancer treatment. Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program The drugmaker will cover the cost of testing for up to 500 patients in the US with MSI-high colorectal cancer or RAI-refractory differentiated thyroid cancer. Apr 30, 2020 Bayer, OrigiMed Form Companion Diagnostic Development Alliance Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium May 29, 2019 Bayer, Foundation Medicine Partner on NGS-Based Companion Diagnostic Test Development Apr 26, 2019 European Project Aims to Develop Tools, Guidelines to Improve Data Sharing, Access Premium Apr 2, 2019 Bayer, Loxo Next-Generation TRK Inhibitor Shows Promising Activity in AACR Study Premium Nov 27, 2018 Loxo's Pan-Cancer Drug Garners FDA Approval for Patients With NTRK Fusions Oct 31, 2018 Bayer Rolling Out Portal for Translational Research Data Sharing Premium Jun 29, 2018 Bayer, Broad Institute Expand Cardiovascular Disease Research Alliance Dec 14, 2017 Ginkgo Bioworks Raises $275M to Support Foundry, Bayer Ag Venture Nov 27, 2017 European Consortium Aims to Deliver New Tests, Therapies for Cardiovascular Diseases Premium Oct 3, 2017 Ginkgo Bio Invests $10M in Transcriptic, Inks Supply Deal With Twist Bioscience Dec 21, 2016 Bayer, Leica Biosystems Collaborate on CDx for Cancer Therapies Jul 18, 2016 T2 Biosystems, Bayer Ink Hemostasis R&D Deal May 17, 2016 Bayer Inks CRISPR Patent Licensing Agreement Mar 23, 2016 XCell Biosciences Aims to Improve CTC Analysis, Biomarker Discovery With New Cell Culture Platform Premium Dec 21, 2015 Bayer, CRISPR Therapeutics Launch JV to Develop CRISPR/Cas9 Treatments Mar 31, 2015 Bayer, Broad Expand Collaboration to Include Cardiovascular Genomics Sep 5, 2014 MediSapiens Ramping Up US Operations, Developing Clinical Solution, Looking Beyond Oncology Premium May 16, 2014 Bayer Healthcare Taps MediSapiens' to Provide Genome Data Analysis, Storage Premium May 8, 2014 Cenix Inks Research Deal with Bayer Premium Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.